Login to Your Account

To Partner, To Merge? CEOs Probe Issues At BIO Conference

By Randall Osborne

Monday, February 25, 2002
NEW YORK - The nitty-gritty of strategy, partnering and navigating the FDA were among topics covered during the fourth annual BIO CEO & Investor Conference last week, where about 1,500 registrants crowded the meeting rooms of the Waldorf-Astoria Hotel to hear some of the industry's leaders talk about what worked for them, and what didn't. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription